Alphatec vs iRhythm
Alphatec reported revenue of $764 million in fiscal 2025, about the same as iRhythm's $747 million in fiscal 2025. Alphatec's revenue grew 24.9% in its latest year, and iRhythm's grew 26.2%. Alphatec had an operating margin of -10.8%, against -7.7% at iRhythm. Free cash flow was $3 million at Alphatec and $35 million at iRhythm.
Side by side
| Alphatec | iRhythm | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $764M | $747M |
| Revenue growth | 24.9% | 26.2% |
| Revenue growth a year, last 5 years | 39.5% | 23.0% |
| Gross margin | 69.6% | 70.6% |
| Operating margin | −10.8% | −7.7% |
| Net margin | −18.8% | −6.0% |
| Free cash flow | $3M | $35M |
| Free cash flow margin | 0.4% | 4.6% |
| Return on capital | −14.3% | −12.4% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 5.0% | 2.6% |
| Last close | $7.07 | $91.91 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | bought $56,892, sold $22.7 million |
| Piotroski F-score | 5 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AlphateciRhythm
Operating margin
Percent of revenue
AlphateciRhythm
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AlphateciRhythm